• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Dermata Therapeutics Inc (NQ: DRMA )

    1.270 -0.080 (-5.93%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Oct 31, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Dermata Therapeutics Inc

    < Previous 1 2 3 4 5 6 7 8 9 Next >
    Why Vaxcyte Shares Are Trading Sharply Higher? Here Are 63 Stocks Moving In Monday's Mid-Day Session
    Gainers Vaxcyte, Inc. (NASDAQ: PCVX) shares jumped 65% to $33.96 after the company announced positive topline results from the Phase 1/2 clinical proof-of-concept study evaluating the safety,... 
    Via Benzinga
    12 Health Care Stocks Moving In Wednesday's After-Market Session
    Gainers Pulmatrix (NASDAQ:PULM) shares rose 11.9% to $4.3 during Wednesday's after-market session. The company's market cap stands at $14.5 million. 
    Via Benzinga
    Why Allena Pharmaceuticals Tumbled Over 30%; Here Are 85 Biggest Movers From Yesterday
    Gainers Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ: SHPH) shares jumped 91.3% to close at $28.50 on Tuesday amid post-IPO volatility. 
    Via Benzinga
    Dermata to Present at the H.C. Wainwright 24th Annual Global Investment Conference
    Via ACCESSWIRE
    Dermata to Participate in the Gilmartin Group Emerging Growth Company Showcase
    Via ACCESSWIRE
    Why Hill International Shares Are Trading Higher By 58%: Here Are 25 Stocks Moving Premarket
    Gainers Hill International, Inc. (NYSE: HIL) shares rose 58.1% to $2.75 in pre-market trading after the company agreed to be acquired by Global Infrastructure Solutions Inc. for $2.85 per share. 
    Via Benzinga
    12 Health Care Stocks Moving In Tuesday's After-Market Session
      
    Via Benzinga
    Dermata Therapeutics: Q2 Earnings Insights
      Dermata Therapeutics (NASDAQ:DRMA) reported its Q2 earnings results on Monday, August 15, 2022 at 04:05 PM. Here's what investors need to know about the announcement. 
    Via Benzinga
    Dermata Therapeutics Provides Corporate Update and Reports Second Quarter 2022 Financial Results
    Via ACCESSWIRE
    12 Health Care Stocks Moving In Monday's After-Market Session
    Gainers Conformis (NASDAQ:CFMS) shares moved upwards by 13.2% to $0.29 during Monday's after-market session. The company's market cap stands at $53.5 million. 
    Via Benzinga
    12 Health Care Stocks Moving In Wednesday's Pre-Market Session
      
    Via Benzinga
    12 Health Care Stocks Moving In Tuesday's Intraday Session
      
    Via Benzinga
    Why This Biotechnology Surged More Than 60%; Here Are 67 Biggest Movers From Yesterday
    Gainers Ayala Pharmaceuticals, Inc. (NASDAQ: AYLA) shares surged 94.3% to close at $1.69 on Tuesday after the company filed a request for the withdrawal of the Registration Statement on Form S-1. 
    Via Benzinga
    12 Health Care Stocks Moving In Thursday's Intraday Session
    Via Benzinga
    Tesla, Twitter And 76 Biggest Movers From Friday
    Gainers Seritage Growth Properties (NYSE: SRG) shares surged 80.3% to settle at $10.96 after the company appointed Adam Metz as Chairman. Preliminary proxy materials also indicated the board... 
    Via Benzinga
    Why Is Akebia Therapeutics Surging By 28%? 48 Stocks Moving In Friday's Mid-Day Session
    Gainers Quoin Pharmaceuticals, Ltd. (NASDAQ: QNRX) rose 56.1% to $ 0.7029 after dropping 10% on Thursday. 
    Via Benzinga
    This Low-Float Stock Jumps Around 148%; Here's 64 Biggest Movers From Yesterday
    Gainers United Maritime Corporation (NASDAQ: USEA) climbed 147.6% to close at $7.08 on Thursday on heavy momentum following the company's recent listing on the Nasdaq Capital Market. 
    Via Benzinga
    12 Health Care Stocks Moving In Friday's Pre-Market Session
    Via Benzinga
    Accolade Shares Jump Around 29%, Here's 75 Biggest Movers From Friday
    Gainers Omeros Corporation (NASDAQ: OMER) jumped 68.7% to close at $4.64. Clovis Oncology, Inc. (NASDAQ: CLVS) gained 58.3% to settle at $2.85 on Friday. 
    Via Benzinga
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
    Good morning, trader! It's time for another look at the biggest pre-market stock movers as we dive into the latest news for Friday! 
    Via InvestorPlace
    Akebia Therapeutics And 20 Stocks Moving Premarket
    Gainers Quoin Pharmaceuticals, Ltd. (NASDAQ: QNRX) rose 83.2% to $0.8250 in pre-market trading after dropping 10% on Thursday. 
    Via Benzinga
    Akerna Shares Dip 53%, Here's 78 Biggest Movers From Yesterday
    Gainers Revelation Biosciences, Inc. (NASDAQ: REVB) surged 77.4% to close at $1.11 on Thursday after jumping 27% on Wednesday. Revelation Biosciences recently announced completion of dosing for Phase... 
    Via Benzinga
    12 Health Care Stocks Moving In Thursday's After-Market Session
    Gainers 
    Via Benzinga
    Why Is NeuroSense Therapeutics Jumping By 45%? 64 Stocks Moving In Thursday's Mid-Day Session
    Gainers Revelation Biosciences, Inc. (NASDAQ: REVB) jumped 171.3% to $1.70 after jumping 27% on Wednesday. Revelation Biosciences recently announced completion of dosing for Phase 1b CLEAR clinical... 
    Via Benzinga
    Dermata Announces Final Patient Enrolled in a Phase 2 Trial of DMT310 for the Once-Weekly Treatment of Moderate-to-Severe Rosacea
    - Topline results expected in the second half of 2022 - 
    From Dermata Therapeutics
    Via AccessWire
    Dermata to Present at the H.C. Wainwright Global Investment Conference
    SAN DIEGO, CA / ACCESSWIRE / May 23, 2022 / Dermata Therapeutics, Inc. (NASDAQ:DRMA) ("Dermata" or the "Company"), a clinical-stage biotechnology company focusing on the treatment of medical and... 
    From Dermata Therapeutics
    Via AccessWire
    Dermata Therapeutics Provides Corporate Update and Reports First Quarter 2022 Financial Results
    Dermata completes a $5.0 million private placement financing DMT310 Phase 2 rosacea trial topline results expected in H2 2022 SAN DIEGO, CA / ACCESSWIRE / May 16, 2022 / Dermata Therapeutics, Inc.... 
    From Dermata Therapeutics
    Via AccessWire
    Exposures Product Safety
    12 Health Care Stocks Moving In Monday's Pre-Market Session
    Via Benzinga
    Dermata Therapeutics Announces Closing of $5.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules
    SAN DIEGO, CA / ACCESSWIRE / April 25, 2022 / Dermata Therapeutics, Inc. ("Dermata," or the "Company") (NASDAQ:DRMA) (NASDAQ:DRMAW), a clinical-stage biotechnology company focusing on the treatment of... 
    From Dermata Therapeutics
    Via AccessWire
    Dermata Therapeutics Announces $5.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules
    SAN DIEGO, CA / ACCESSWIRE / April 21, 2022 / Dermata Therapeutics, Inc. ("Dermata," or the "Company") (NASDAQ:DRMA) and (NASDAQ:DRMAW), a clinical-stage biotechnology company focusing on the treatment... 
    From Dermata Therapeutics
    Via AccessWire
    < Previous 1 2 3 4 5 6 7 8 9 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.